BUSINESS ACQUIRED

12 Months Ended

Jun. 30, 2026

Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]

BUSINESS ACQUIRED

BUSINESS ACQUIRED

On April 1, 2026, the Company completed the acquisition of GOJO Industries, Inc. (GOJO), makers of Purell and a leader of skin health and hygiene solutions. The Company acquired all of the issued and outstanding membership interests of GOJO, which is based in northeast Ohio. The acquisition reflects the Company's strategy to expand its position in health and hygiene and accelerate profitable growth. The acquired business now operates as Clorox Purell and is included within the Professional Products operating segment.

The acquisition was completed for cash consideration of approximately $2,147, which includes post-closing working capital and other adjustments, and was funded through commercial paper borrowings and new debt. See Note 11 for additional details.

The GOJO acquisition was accounted for as a business combination under the acquisition method of accounting. The purchase consideration was allocated to the tangible and identifiable intangible assets acquired and liabilities assumed based on their fair values at the acquisition date, with the excess allocated to goodwill. This allocation was performed based on information available at the acquisition date and is subject to change during the measurement period not to exceed one year. Clorox Purell's operating results and all of the goodwill derived from the acquisition are included within the Health and Wellness reportable segment. The goodwill derived from this acquisition is expected to be deductible for tax purposes. The goodwill represents expected synergies from complementary expertise and business-to-business capabilities as well as both near-term and long-term strategic value to the Company.

The purchase consideration recorded as of June 30, 2026 includes an estimate of the contractual net working capital adjustment. The net working capital adjustment has not yet been finalized and, therefore, consideration transferred, goodwill, and working capital amounts remain provisional. The Company expects to finalize these amounts during the measurement period.

The following table summarizes the preliminary fair values of the assets acquired and liabilities assumed as of the acquisition date.

	Initial Allocation
Assets acquired:
Cash and cash equivalents	$	44
Receivables, net	113
Inventories, net	183
Prepaid expenses and other current assets	13
Property, plant and equipment, net	259
Operating lease right-of-use-assets	6
Goodwill	717
Trademarks, net	487
Other intangible assets, net	569
Other assets (non-current)	43
Total assets acquired	$	2,434
Liabilities assumed:
Accounts payable and accrued liabilities	$	227
Current operating lease liabilities	3
Income taxes payable	2
Current maturities of long-term debt	2
Long-term debt	6
Long-term operating lease liabilities	2
Other liabilities (non-current)	42
Total liabilities assumed	$	284
Less: Noncontrolling interests	(3)
Purchase consideration	$	2,147

Trademarks acquired include $465 assigned an indefinite useful life and $22 assigned a useful life of 15 years. Acquired intangible assets included in Other intangible assets, net are made up of customer relationships valued at $547 and assigned a useful life of 20 years and developed technology valued at $22 and assigned a useful life of 7 years.

For fiscal year 2026, the Company recognized $211 of Net sales and $6 of Net earnings attributable to Clorox from GOJO from the acquisition date through June 30, 2026.

Pro Forma Financial Information

The following supplemental unaudited pro forma information gives effect to the GOJO acquisition as though it had occurred on July 1, 2024. The pro forma information reflects certain adjustments to net earnings to conform to this hypothetical acquisition date. Adjustments, which are directly attributable to the acquisition and factually supportable, include, but are not limited to:

•Excluded charges of $29 recognized in cost of products sold from fiscal year 2026, and added $39 of such charges to fiscal year 2025, representing expense recognition of inventory fair value adjustments in excess of the historical cost basis;

•Added interest expense of $81 and $113 to fiscal years 2026 and 2025, respectively, related to debt incurred to fund the acquisition assuming no deleveraging;

•Excluded transaction costs of $29 primarily recognized in selling and administrative expenses from fiscal year 2026 and added $22 of such costs to fiscal year 2025 to reflect the hypothetical timing of the pro forma acquisition date;

•Applied an effective tax rate of approximately 24% to the net impact of all adjustments in both fiscal years 2026 and 2025.

Pro Forma (unaudited)	2026		2025
Net sales	$	7,331	$	7,882
Net earnings attributable to Clorox	625		715

The supplemental unaudited pro forma information is provided for informational purposes only and is not necessarily indicative of the results that would have been achieved had the acquisition occurred on the date indicated, nor is it necessarily indicative of future results. The pro forma information does not reflect any operating efficiencies, cost savings, or other synergies that may result from the acquisition.